Article
Guidelines From the French-Speaking Society for Histocompatibility and Immunogenetics (SFHI) for Harmonisation of HLA Genotyping in Autoimmune Diseases, Drug Hypersensitivity and Pharmacogenetics.
HLA - 1 Oct 2025
Renac Virginie, Moalic Virginie, Dautin Guillaume, Cherel Mathilde, Mercier Bernard, Walencik Alexandre, Cohen Jacques, Farce Fabienne, Proust Barbara, Kaveri Rangolie, Humeau Camille, Picard Christophe, Pedron Béatrice, Dubois Valérie, Taupin Jean-Luc, Elsermans Vincent, Top-Raymond Isabelle, Ferrari-Lacraz Sylvie, Barocas Antoine, Masson Dominique, Essaydi Arnaud, Guidicelli Gwendaline, Ralazamahaleo Mamy, Congy-Jolivet Nicolas
Abstract excerpt
HLA molecules play a central role in the adaptive immune response. Their high polymorphism influences individual susceptibility to various autoimmune diseases and certain drug-induced hypersensitivities. In France, HLA genotyping is classified as a medical genetics procedure and is strictly regulated. The Société Francophone d'Histocompatibilité et d'Immunogénétique (SFHI) has established national guidelines...
Read the complete abstract on PubMedTopics
- Humans
- Autoimmune Diseases
- Pharmacogenetics
